--- title: "Cosmetic Challenge Testing vs Microbial Limits" description: "Preservative efficacy (challenge) testing and microbiological quality testing answer different questions. Learn what each covers under ISO 11930 and ISO 17516 and what to request." image: "https://cosmetic-labs.com/wp-content/uploads/67002-microbiology-evidence-scopes-1200x1200-1.webp" --- # Cosmetic Challenge Testing vs Microbial Limits > Preservative efficacy (challenge) testing and microbiological quality testing answer different questions. Learn what each covers under ISO 11930 and ISO 17516 and what to request. Source: https://cosmetic-labs.com/articles/cosmetic-challenge-test-microbial-limits Created: 2026-10-23T17:32:49+00:00 Modified: 2026-10-25T15:34:40+00:00 Author: Emilie SCHOL Cosmetic Challenge Testing vs Microbial Limits | Cosmetic Labs ## **Key takeaways** ISO 11930 addresses evaluation of antimicrobial protection, including preservation-efficacy testing and microbiological risk assessment. ISO 17516 addresses microbiological limits and assessment of product microbiological quality. A report about tested material does not automatically answer the formulation-protection question. Ask a qualified provider to justify which evidence applies to the identified product. Do not turn the abstracts’ low-risk qualifications into blanket exemptions. Request the method, edition, applicable criteria, limitations and technical interpretation. The catalogue abstracts alone do not establish those details. Preservative efficacy testing and microbiological quality testing answer different questions. The first asks how well a formulation’s preservation protects it against microbial contamination. The second asks about the microbiological quality of the material examined. Neither report is a general certificate that a product is safe, stable or ready to launch, and one cannot stand in for the other. This comparison uses the official ISO catalogue abstracts to explain the difference at buyer-planning level. Use the [cosmetic product development roadmap](https://cosmetic-labs.com/cosmetic-product-development-guide) to fit microbial evidence into the product’s wider assessment and release decisions. ## Compare the question before comparing reports Neither test is “better”. They have different purposes. The [ISO 11930 abstract](https://www.iso.org/standard/75058.html) covers antimicrobial protection and preservation-efficacy evidence. The [ISO 17516 abstract](https://www.iso.org/standard/59938.html) covers the assessment of microbiological quality. The matrix summarizes those scopes in plain terms. It is not quoted from either standard. Buyer questionPreservation-efficacy / antimicrobial-protection evidenceMicrobiological-quality evidenceWhat is being considered?Preservation of the formulation and evaluation of overall antimicrobial protectionMicrobiological quality of the product material examinedWhich verified ISO scope is relevant?ISO 11930 catalogue abstractISO 17516 catalogue abstractWhat should the provider explain?How preservation-efficacy evidence, risk assessment or both inform protection evaluationWhat the test examined and how its findings inform quality assessmentWhat needs identification?Formula, sample, relevant product configuration and scopeSample or batch reference, source and applicable test scopeWhat must not be inferred automatically?Quality of every commercial batch or complete product safetyPreservation performance of the formulation or quality of future batchesWhat remains product-specific?Applicability, methods, interpretation and any further workApplicability, methods, sampling basis, interpretation and any further workBefore you accept a “microbiology passed” summary, ask the provider which of these questions the report answers. Formula, pack and dispensing questions belong to the separate [stability and packaging compatibility guide](https://cosmetic-labs.com/cosmetic-stability-packaging-compatibility-testing). ## What does preservative efficacy testing address? It addresses how well a cosmetic formulation is preserved. The [ISO 11930:2019 abstract](https://www.iso.org/standard/75058.html) calls its preservation-efficacy test a reference method for evaluating the preservation of a cosmetic formulation. It also sets out how to interpret data from that test, from a microbiological risk assessment, or from both, when evaluating overall antimicrobial protection. The abstract says the test is primarily designed for water-soluble or water-miscible products. “Challenge test” is the common service name for this kind of work. For EU products, [Annex I of Regulation (EC) No 1223/2009](https://publications.europa.eu/resource/cellar/9382f98e-9b27-11f1-b25c-01aa75ed71a1.0001.02/DOC_1#anx_I) lists “results of preservation challenge test” under microbiological quality in the safety report. A quotation that says “challenge test” still needs to name the actual method, edition and report scope. ISO 11930 is not one mandatory experiment for every cosmetic. Its abstract includes risk-assessment and low-risk qualifications. It does not let this guide prescribe sample preparation, organisms, time points or acceptance limits. The question to put to the provider is: “What evidence supports the antimicrobial-protection assessment for this formulation, and what are its limits?” Ask the technical reviewer which product configuration the conclusion covers and which later changes would need an applicability review. ## What does microbiological quality testing address? It addresses the quality of the material examined. It says nothing directly about preservation performance. The [ISO 17516:2014 abstract](https://www.iso.org/standard/59938.html) says the standard helps interested parties assess microbiological quality, and that products considered microbiologically low risk do not need testing. The title refers to microbiological limits, but the abstract gives no numerical limits or sampling plan. For a report tied to a production batch, request the batch and sample references, how the sample was identified and how far the provider’s interpretation extends. Ask what supports any statement about the wider batch. A result for one identified sample is not a guarantee about every unit or about future production. Sample-quality evidence matters, but only for the question it answers. A report can support a defined quality decision and still leave the formulation’s antimicrobial-protection assessment open. If a supplier sends only a summary or certificate, ask for the agreed report and its scope. The decision needs enough context to separate what was measured, what was concluded and what is still unknown. The [development roadmap](https://cosmetic-labs.com/cosmetic-product-development-guide) keeps that decision separate from product-wide launch approval. ## Ask for a qualified risk-based plan, not a blanket exemption A low-risk conclusion needs a product-specific assessment that can be defended. A marketing description does not qualify. The [ISO 11930 abstract](https://www.iso.org/standard/75058.html) says its test does not apply to products whose microbiological risk has been determined to be low according to its Annex A and ISO 29621. The [ISO 17516 abstract](https://www.iso.org/standard/59938.html) carries a similar qualification for testing. An ingredient preference, a pack claim or a product category does not by itself create an exemption. Ask the qualified provider and the safety assessor to explain the basis for their recommendation, the product information they need and the limits of the conclusion. A useful planning conversation covers: The product and intended use under assessment. - Existing evidence and whether it applies to the current version. - The preservation and quality questions that need answering. - The recommended evidence and the reason for any work left out. - Who reviews the conclusion and which changes would reopen it. **This is not a guide to home microbial testing.** Do not use the comparison to design experiments, and do not treat an informal trial as product evidence. The [stability and pack request](https://cosmetic-labs.com/cosmetic-stability-packaging-compatibility-testing) runs alongside the qualified microbial plan and does not replace it. ## Request a report that supports an identified decision Agree purpose, method, scope and interpretation before commissioning work. The checklist is a request format. It is not an ISO report structure or a laboratory protocol. REQUEST ID / VERSION / DATE: BRAND CONTACT / QUALIFIED TECHNICAL REVIEWER: DECISION THIS EVIDENCE SHOULD SUPPORT: PRODUCT AND SAMPLE - Product name, formula version and intended use: - Relevant pack configuration and known changes: - Sample/batch identity, source and receipt arrangements: - Existing reports and their applicability questions: PURPOSE TO CONFIRM - Antimicrobial-protection / preservation-efficacy question: - Microbiological-quality question: - Proposed evidence and product-specific rationale: - Basis and owner of any low-risk determination: METHOD AND REPORT SCOPE TO REQUEST - Method, edition and applicable amendments: - Applicable acceptance criteria and interpretation basis: - Work included, excluded or subcontracted: - Sample identification and relevant deviations: - Findings, technical interpretation and limitations: - Unexpected/inconclusive finding notification process: DECISION HANDOFF - Evidence reviewer and decision authority: - Unresolved questions and owner: - Further work or information required: - Change triggers and applicability-review process: - What may proceed and what remains on hold: **Ask the provider for the criteria. Do not supply your own.** The checklist lists what to obtain. It does not specify organisms, counts, time points or analytical steps. Ask which edition and amendments the method statement covers and how any deviation affects interpretation. Before accepting the report, check that the product and sample identities, purpose and completed work match the request. Keep the laboratory’s findings separate from the wider decision made by the product reviewer. A filename or a single pass label does not establish either. ## Keep the handoff narrower than product-wide approval A decision record should state which question is resolved and which is still open. This invented example shows a purpose mismatch. It contains no measured result. **Project:** moisturizer M01, formula F03, batch B02; record H01 dated 23 October 2026. **Evidence received:** document Q01, described as a microbiological-quality report for a sample from B02. **Question still open:** what evidence supports the antimicrobial-protection evaluation for F03? Q01 does not answer that. **Owner:** brand technical coordinator obtains the relevant evidence, or a documented product-specific recommendation, from the qualified provider. **Separate review:** the quality reviewer assesses Q01 for its own sample/batch decision. No pass is assumed. **Decision:** hold the protection-related approval and any release commitment that depends on it. **Reopening condition:** reviewers document which evidence applies, its limits, any remaining work and the decision it supports. The hold does not mean a particular experiment is always required. It stops one report from quietly clearing a different question. Use the [cosmetic pilot batch and scale-up checklist](https://cosmetic-labs.com/cosmetic-formulation-scale-up/) to link this evidence to production records and later changes. ## Confirm editions before commissioning work The sources here are catalogue abstracts, not the full standards. This matters when a provider calls a service “ISO compliant” or names an edition without describing the method. On 23 October 2026 the [ISO 11930 catalogue page](https://www.iso.org/standard/75058.html) listed ISO 11930:2019, Amendment 1:2022 and a successor draft under development. The [ISO 17516 catalogue page](https://www.iso.org/standard/59938.html) showed the 2014 edition as confirmed and current, with a revision under development. Ask the provider which edition and amendments it applies, and do not assume a draft has replaced the published text. No full standard, organism list, numerical criteria, sampling scheme or protocol is given here. The comparison shows that the purposes differ. It is not a certification finding, a shelf-life guarantee or a product-safety conclusion. ## Next step: send the question and the product references together Decide whether you need evidence on formulation protection, on the quality of tested material, or both. Then ask a qualified provider to justify the plan. Send the current product references and ask for an interpretation with explicit limits. Keep the [development roadmap](https://cosmetic-labs.com/cosmetic-product-development-guide) and the [stability/packaging guide](https://cosmetic-labs.com/cosmetic-stability-packaging-compatibility-testing) alongside the microbial request so that no single report stands in for the whole launch decision. Author: Emilie SCHOL Founder of Cosmetic Labs, the B2B platform connecting cosmetic brands with labs, CROs and raw-material suppliers. Former Business Development Manager at QIMA Life Sciences (cosmetic & pharma CRO). Based in Toulouse, France. Updated on October 25, 2026 First posted on October 23, 2026 Sources ## Sources and references References supporting this page are listed below. Source access dates and supported claims are recorded in the evidence notes where available. [ISO 11930:2019 Cosmetics – Microbiology – Evaluation of the antimicrobial protection of a cosmetic product](https://www.iso.org/standard/75058.html) URL [https://www.iso.org/standard/75058.html](https://www.iso.org/standard/75058.html) Publisher International Organization for Standardization [ISO 17516:2014 Cosmetics – Microbiology – Microbiological limits](https://www.iso.org/standard/59938.html) URL [https://www.iso.org/standard/59938.html](https://www.iso.org/standard/59938.html) Publisher International Organization for Standardization [Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast)](https://publications.europa.eu/resource/cellar/9382f98e-9b27-11f1-b25c-01aa75ed71a1.0001.02/DOC_1) URL [https://publications.europa.eu/resource/cellar/9382f98e-9b27-11f1-b25c-01aa75ed71a1.0001.02/DOC_1](https://publications.europa.eu/resource/cellar/9382f98e-9b27-11f1-b25c-01aa75ed71a1.0001.02/DOC_1) Author European Parliament and Council of the European Union Publisher Publications Office of the European Union Date May 18, 2026 [ISO 29621:2017 Cosmetics – Microbiology – Guidelines for the risk assessment and identification of microbiologically low-risk products](https://www.iso.org/standard/68310.html) URL [https://www.iso.org/standard/68310.html](https://www.iso.org/standard/68310.html) Publisher International Organization for Standardization FAQ ## Frequently asked questions ### Can microbial-limit results replace a preservative challenge test? No. Microbiological-quality testing addresses the material examined, while preservation-efficacy evidence addresses how the formulation is protected against contamination. A satisfactory sample-quality result does not establish preservation performance. Ask the qualified provider to identify which question each report answers and whether the antimicrobial-protection assessment still needs evidence or a documented product-specific risk assessment. ### Can low-risk cosmetics avoid microbiological testing? Some products assessed as microbiologically low risk may not need the relevant testing. ISO 11930 and ISO 17516 include low-risk qualifications, and ISO 29621 provides risk-assessment guidance. Have a qualified reviewer document why the actual finished product qualifies. A product-category label, packaging description or ingredient preference alone does not establish that conclusion. ### Does a passing sample result cover every production batch? No. A result concerns the identified material examined and the scope of the test. Ask how the sample was obtained, which batch it represents and what supports any wider interpretation. Keep future-batch quality and formulation protection as separate questions. A brief certificate without sample identity or report scope cannot resolve those questions. ### What should a microbiology testing quote specify? The quote should identify the product and sample, the evidence question, the method edition and amendments, and the report’s interpretation limits. Ask the provider to state applicable criteria, exclusions and handling of unexpected findings. Agree who reviews the evidence and decides what may proceed, rather than accepting an undefined microbiology-pass package. ### Is an ISO catalogue abstract enough to set test limits? No. A catalogue abstract establishes a standard’s scope, not its complete laboratory procedure or numerical acceptance criteria. Ask a qualified provider to identify the applicable published edition and amendments and explain its interpretation. A draft revision does not automatically replace the published standard, and this comparison does not provide a home-testing protocol. Continue with [Google](https://cosmetic-labs.com/?lean_auth=start&provider=google&redirect_to=https://cosmetic-labs.com/&error_return=https://cosmetic-labs.com/articles/cosmetic-challenge-test-microbial-limits) [LinkedIn](https://cosmetic-labs.com/?lean_auth=start&provider=linkedin&redirect_to=https://cosmetic-labs.com/&error_return=https://cosmetic-labs.com/articles/cosmetic-challenge-test-microbial-limits) © 2026 Cosmetic Labs. All rights reserved. --- ## Site identity - Organization: Cosmetic Labs - Description: Cosmetic Labs is a directory and a platform to meet all your cosmetic product development needs. From sourcing raw material to finding the best CRO for your needs. - Website: https://cosmetic-labs.com ```json [{"@type":"Article","headline":"Cosmetic Challenge Testing vs Microbial Limits","url":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits","mainEntityOfPage":{"@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits#webpage"},"image":{"@type":"ImageObject","url":"https:\/\/cosmetic-labs.com\/wp-content\/uploads\/67002-microbiology-evidence-scopes-1200x1200-1-1024x1024.webp","width":1024,"height":1024,"caption":"Closed cosmetic sample pot and covered Petri dish beside a rack of capped formulation sample vials."},"datePublished":"2026-10-23T17:32:49+00:00","dateModified":"2026-10-25T15:34:40+00:00","author":{"@type":"Person","name":"Emilie SCHOL","url":"https:\/\/cosmetic-labs.com\/members\/39984"},"inLanguage":"en-US","publisher":{"@id":"https:\/\/cosmetic-labs.com#organization"},"citation":[{"@type":"CreativeWork","name":"ISO 11930:2019 Cosmetics \u2013 Microbiology \u2013 Evaluation of the antimicrobial protection of a cosmetic product","url":"https:\/\/www.iso.org\/standard\/75058.html","publisher":{"@type":"Organization","name":"International Organization for Standardization"}},{"@type":"CreativeWork","name":"ISO 17516:2014 Cosmetics \u2013 Microbiology \u2013 Microbiological limits","url":"https:\/\/www.iso.org\/standard\/59938.html","publisher":{"@type":"Organization","name":"International Organization for Standardization"}},{"@type":"CreativeWork","name":"Regulation (EC) No 1223\/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast)","url":"https:\/\/publications.europa.eu\/resource\/cellar\/9382f98e-9b27-11f1-b25c-01aa75ed71a1.0001.02\/DOC_1","datePublished":"2026-05-18","author":{"@type":"Person","name":"European Parliament and Council of the European Union"},"publisher":{"@type":"Organization","name":"Publications Office of the European Union"}},{"@type":"CreativeWork","name":"ISO 29621:2017 Cosmetics \u2013 Microbiology \u2013 Guidelines for the risk assessment and identification of microbiologically low-risk products","url":"https:\/\/www.iso.org\/standard\/68310.html","publisher":{"@type":"Organization","name":"International Organization for Standardization"}}],"@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits#article"},{"@type":"WebPage","name":"Cosmetic Challenge Testing vs Microbial Limits","url":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits","mainEntity":{"@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits#article"},"isPartOf":{"@id":"https:\/\/cosmetic-labs.com\/articles#webpage"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cosmetic-labs.com\/"},{"@type":"ListItem","position":2,"name":"Blog","item":"https:\/\/cosmetic-labs.com\/articles"},{"@type":"ListItem","position":3,"name":"Cosmetic Challenge Testing vs Microbial Limits","item":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits"}]},"inLanguage":"en-US","@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-challenge-test-microbial-limits#webpage"}] ```